Assenagon Asset Management
BEAT

Assenagon Asset Management’s BioTelemetry, Inc. BEAT Stock Holding History

Assenagon Asset Management’s Portfolio BEAT Stock Details BEAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-4,370
Closed -$202K – 1076
2019
Q4 		$202K Buy
+4,370
New +$189K ﹤0.01% 729

Other funds holding BEAT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Assenagon Asset Management's BEAT Position: Q1 2020 in Review

Assenagon Asset Management sold out of BioTelemetry, Inc. (BEAT) in Q1 2020, closing a stake of 4,370 shares — an estimated $202K sold.

Assenagon Asset Management first reported a position in BEAT in Q4 2019 and held it in 1 quarter. The position peaked at $202K in Q4 2019. 209 funds tracked by Wall St. Rank hold BEAT as of Q1 2020.

  • Assenagon Asset Management reported no remaining BioTelemetry, Inc. position as of Q1 2020 after selling out during the quarter.
  • Assenagon Asset Management sold 4,370 BioTelemetry, Inc. shares in Q1 2020, an estimated $202K.
  • Assenagon Asset Management first reported a position in BioTelemetry, Inc. in Q4 2019 and held it in 1 quarter.
  • Assenagon Asset Management's BioTelemetry, Inc. position peaked at $202K in Q4 2019.
  • 209 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2020.

Based on Assenagon Asset Management's 13F filing for Q1 2020, filed 17 Apr 2020.